FDA Roundup: March 21, 2025

News Healthcare & Pharma General Updates

Date: 21st Mar, 2025 Source: Food and Drug Administration (FDA) Country: USA Original Source

Brief

On 03/21/2025, the Food and Drug Administration (FDA) issued an update regarding FDA Roundup: March 21, 2025. The agency approved Fabhalta for treating adults with complement 3 glomerulopathy (C3G), a rare kidney disease. Additionally, FDA authorized marketing for the CORIS System, an automated endoscope cleaner, and updated instructions for use of Calyxo CVAC Aspiration Systems were issued as part of the medical device recall program pilot.

This content is restricted.

Highlights content goes here...

This content is restricted.

Food and Drug Administration (FDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

FDA Roundup: March 21, 2025

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

FDA Roundup: March 21, 2025

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.